pH-Triggered Drug-Releasing Magnetic Nanoparticles for Cancer Therapy Guided by Molecular Imaging by MRI
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Eun-Kyung | - |
dc.contributor.author | Huh, Yong-Min | - |
dc.contributor.author | Yang, Jaemoon | - |
dc.contributor.author | Lee, Kwangyeol | - |
dc.contributor.author | Suh, Jin-Suck | - |
dc.contributor.author | Haam, Seungjoo | - |
dc.date.accessioned | 2021-09-07T11:40:47Z | - |
dc.date.available | 2021-09-07T11:40:47Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-06-03 | - |
dc.identifier.issn | 0935-9648 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/112249 | - |
dc.description.abstract | pH-sensitive drug-delivering magnetic nanoparticles (DMNPs) have been developed as theragnostic nanocarriers that release doxorubicin (DOX) under acidic conditions within cancer cells. The drug release kinetics of the DMNPs, combined with the nanoparticle accumulation pattern in tumor cells, can be monitored by magnetic resonance imaging (MRI) to guide decisions regarding the optimization of drug dosing schedules. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.subject | BREAST-CANCER | - |
dc.subject | IN-VIVO | - |
dc.subject | BIOMEDICAL APPLICATIONS | - |
dc.subject | CONTRAST AGENTS | - |
dc.subject | FATTY ACID | - |
dc.subject | DELIVERY | - |
dc.subject | TUMOR | - |
dc.subject | NANOCARRIERS | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | PLATFORM | - |
dc.title | pH-Triggered Drug-Releasing Magnetic Nanoparticles for Cancer Therapy Guided by Molecular Imaging by MRI | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwangyeol | - |
dc.identifier.doi | 10.1002/adma.201100351 | - |
dc.identifier.scopusid | 2-s2.0-79957815663 | - |
dc.identifier.wosid | 000291732000006 | - |
dc.identifier.bibliographicCitation | ADVANCED MATERIALS, v.23, no.21, pp.2436 - + | - |
dc.relation.isPartOf | ADVANCED MATERIALS | - |
dc.citation.title | ADVANCED MATERIALS | - |
dc.citation.volume | 23 | - |
dc.citation.number | 21 | - |
dc.citation.startPage | 2436 | - |
dc.citation.endPage | + | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalResearchArea | Physics | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Physical | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Physics, Applied | - |
dc.relation.journalWebOfScienceCategory | Physics, Condensed Matter | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | BIOMEDICAL APPLICATIONS | - |
dc.subject.keywordPlus | CONTRAST AGENTS | - |
dc.subject.keywordPlus | FATTY ACID | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | NANOCARRIERS | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | PLATFORM | - |
dc.subject.keywordAuthor | drug delivery | - |
dc.subject.keywordAuthor | magnetic resonance imaging | - |
dc.subject.keywordAuthor | nanoparticles | - |
dc.subject.keywordAuthor | theragnostics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.